Real-time enrollment status for this non-small-cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 12:28 PM UTC
| NCT Number | NCT07185997 |
| Recruiting Status | Recruiting |
| Condition | Non-Small-Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 480 participants |
| Active Locations | 20 sites in the US |
| Sponsor | ArriVent BioPharma, Inc. |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT07185997 is currently recruiting participants. This phase3 study for non-small-cell lung cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by ArriVent BioPharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07185997 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07185997 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.